<DOC>
	<DOC>NCT01709487</DOC>
	<brief_summary>First line treatment for advanced ovarian carcinoma hyperthermic intraperitoneal chemotherapy (HIPEC) after optimal debulking.</brief_summary>
	<brief_title>Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy</brief_title>
	<detailed_description>Addition of HIPEC to the standard first line treatment of ovarian carcinoma.</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms, Glandular and Epithelial</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<criteria>stage III or only pleural stage IV ovarian carcinoma first line treatment incomplete surgery poor performance status bad general condition</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>HIPEC</keyword>
	<keyword>ovarian carcinoma</keyword>
	<keyword>Bordet</keyword>
</DOC>